Pharmacokinetics and metabolism of Navelbine.
Krikorian
A
A
Centre de Recherche Pierre Fabre, Castres, France.
Rahmani
R
R
Bromet
M
M
Bore
P
P
Cano
J P
JP
D000818:Animals; D000970:Antineoplastic Agents / Q000097:blood / Q000378:metabolism / Q000493:pharmacokinetics*; D055598:Chemical Phenomena; D002621:Chemistry; D006207:Half-Life; D006801:Humans; D008099:Liver / Q000166:cytology / Q000378:metabolism; D008253:Macaca mulatta; D008657:Metabolic Clearance Rate; D051379:Mice; D009369:Neoplasms / Q000378:metabolism*; D009374:Neoplasms, Experimental / Q000378:metabolism; D051381:Rats; D014018:Tissue Distribution; D014316:Tritium; D014747:Vinblastine / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism / Q000493:pharmacokinetics; D014750:Vincristine / Q000493:pharmacokinetics; D014751:Vindesine / Q000493:pharmacokinetics; D000077235:Vinorelbine
D000970:Antineoplastic Agents; D014316:Tritium; D014750:Vincristine; D014747:Vinblastine; D000077235:Vinorelbine; D014751:Vindesine